Guo Guangfeng, Wang Yunting, Kou Wanyu, Gan Hua
Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Front Genet. 2022 Dec 12;13:1062293. doi: 10.3389/fgene.2022.1062293. eCollection 2022.
To provide insights into the diagnosis and therapy of SA-AKI ferroptosis genes. Based on three datasets (GSE57065, GSE30718, and GSE53771), we used weighted co-expression network analysis to identify the key regulators of SA-AKI, its potential biological functions, and constructed miRNA‒mRNA complex regulatory relationships. We also performed machine learning and cell experiments to identify ferroptosis genes that are significantly related to SA-AKI in the two datasets. The CIBERSORT algorithm evaluates the degree of infiltration of 22 types of immune cell. We compared the correlation between ferroptosis and immune cells by Pearson's correlation analysis and verified the key genes related to the immune response to reveal potential diagnostic markers. Finally, we predicted the effects of drugs and the potential therapeutic targets for septic kidney injury by pRRophetic. We found 264 coDEGs involving 1800 miRNA molecules that corresponded to 210 coDEGs. The miRNA‒mRNA ceRNA interaction network was constructed to obtain the top-10 hub nodes. We obtained the top-20 ferroptosis genes, 11 of which were in the intersection. We also identified a relationship between ferroptosis genes and the immune cells in the AKI dataset, which showed that neutrophils were activated and that regulatory T cells were surpassed. Finally, we identified EHT1864 and salubrinal as potential therapeutic agents. This study demonstrated the roles of miR-650 and miR-296-3p genes in SA-AKI. Furthermore, we identified , , , , , , and as potential biomarkers. The irregular immune response mediated by neutrophils and Treg cells is involved in the development of AKI and shows a correlation with ferroptosis genes. EHT 1864 and salubrinal have potential as drug candidates in patients with septic acute kidney injury.
为深入了解脓毒症相关性急性肾损伤(SA-AKI)的诊断和治疗,研究铁死亡基因。基于三个数据集(GSE57065、GSE30718和GSE53771),我们使用加权共表达网络分析来识别SA-AKI的关键调节因子及其潜在生物学功能,并构建了miRNA-mRNA复合调控关系。我们还进行了机器学习和细胞实验,以确定在这两个数据集中与SA-AKI显著相关的铁死亡基因。CIBERSORT算法评估22种免疫细胞的浸润程度。我们通过Pearson相关分析比较了铁死亡与免疫细胞之间的相关性,并验证了与免疫反应相关的关键基因,以揭示潜在的诊断标志物。最后,我们通过pRRophetic预测了药物对脓毒症性肾损伤的影响及潜在治疗靶点。我们发现264个共差异表达基因(coDEGs)涉及1800个miRNA分子,对应210个coDEGs。构建了miRNA-mRNA竞争性内源RNA(ceRNA)相互作用网络,以获得前10个枢纽节点。我们获得了前20个铁死亡基因,其中11个在交集内。我们还确定了AKI数据集中铁死亡基因与免疫细胞之间的关系,结果表明中性粒细胞被激活,调节性T细胞受到抑制。最后,我们确定EHT1864和水杨醛为潜在治疗药物。本研究证明了miR-650和miR-296-3p基因在SA-AKI中的作用。此外,我们确定了……、……、……、……、……、……和……为潜在生物标志物。由中性粒细胞和调节性T细胞介导的不规则免疫反应参与了急性肾损伤的发展,并与铁死亡基因相关。EHT 1864和水杨醛在脓毒症性急性肾损伤患者中具有作为候选药物的潜力。